This brand name is authorized in Nigeria.
The drug FIXTA contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
G07GZ97H65 - CLOTRIMAZOLE
|
|
Clotrimazole acts against fungi by inhibiting ergosterol synthesis. Inhibition of ergosterol synthesis leads to structural and functional impairment of the fungal cytoplasmic membrane. Clotrimazole has a broad antimycotic spectrum of action in vitro and in vivo, which includes dermatophytes, yeasts, moulds, etc. |
|
2
|
UNII
779619577M - CLOBETASOL PROPIONATE
|
|
Clobetasol propionate, like other topical corticosteroids, has anti-inflammatory, antipruritic, and vasoconstrictive properties. Corticosteroids are thought to act by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor arachidonic acid. |
|
3
|
UNII
057Y626693 - NEOMYCIN SULFATE
|
|
Neomycin is an aminoglycoside antibiotic and acts by binding to polysomes, inhibiting protein synthesis and generating errors in the transcription of the genetic code. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| A4-100499 | Cream | FIXTA CREAM CREAM 1%; 0.05%; 0.5% 1X30GX10TUBES | FIXTA CREAM CLOTRIMAZOLE USP 1%W/W, CLOBETASOL DIPROPIONATE USP 0.05%W/W, NEOMYCIN SULFATE USP 0.5%W/W CLOTRIMAZOLE USP 1%W/W, CLOBETASOL DIPROPIONATE USP 0.05%W/W, NEOMYCIN SULFATE USP 0.5%W/W Drugs Imported Products 1X30GX10TUBES POM 1 25/04/2023 TOP UGOLIFE PHARMACEUTICAL CO LTD, 13, JOSEPH ADEBAYOR STREET, AGO PALACE, OKOTA , LAGOS STATE. 8063125746 eugo37@yahoo.com M/S CLAROID PHARMACEUTICAL PVT. LTD., PLOT NO. 217/P, PIRANA-KAMOD ROAD, AHMEDABAD, GUJARAT, INDIA., India | 31/08/2023 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| D07CD01 | Clobetasol and antibiotics | D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07C Corticosteroids, combinations with antibiotics → D07CD Corticosteroids, very potent, combinations with antibiotics |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | A4-100499 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.